| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45963-614-51 | 45963-614 | HUMAN PRESCRIPTION DRUG | Irinotecan hydrochloride | Irinotecan hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20150312 | N/A | ANDA | ANDA078589 | Actavis Pharma, Inc. | IRINOTECAN HYDROCHLORIDE | 20 mg/mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-51) / 2 mL in 1 VIAL, SINGLE-DOSE |
| 45963-614-55 | 45963-614 | HUMAN PRESCRIPTION DRUG | Irinotecan hydrochloride | Irinotecan hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20150312 | N/A | ANDA | ANDA078589 | Actavis Pharma, Inc. | IRINOTECAN HYDROCHLORIDE | 20 mg/mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-55) / 5 mL in 1 VIAL, SINGLE-DOSE |